Recent studies by the Tufts Center for the Study of Drug Development (TCSDD) show that data management solutions supporting clinical development and operations have been changing over time.
In this webinar, hosted by the TCSDD’s Deputy Director Kenneth Getz and Saama’s Chief Strategy Officer, Sagar Anisingaraju, participants will gain insights into:
- Industry benchmarks for clinical data volume and diversity
- Pre- and post-pandemic innovation adoption practices
- Anticipated long-term operating model changes
Speakers
Kenneth Getz, Deputy Director and Professor, Tufts Center for the Study of Drug Development, Tufts University School of Medicine
Kenneth A. Getz is the Deputy Director and a professor at the Tufts Center for the Study of Drug Development, Tufts University School of Medicine, where he conducts research focusing on drug development management and operating strategies and tactics, protocol design practices, global outsourcing, investigative site and patient recruitment practices and policies. He is also the chairman of CISCRP – a nonprofit organization that he founded to educate and raise public and patient awareness of the clinical research enterprise. Getz received an MBA from the J.L. Kellogg Graduate School of Management at Northwestern University and a bachelor’s degree, Phi Beta Kappa, from Brandeis University.
Message Presenter
Sagar Anisingaraju, Chief Strategy Officer, Saama Technologies
Sagar Anisingaraju drives the concepts, business models, and development of Saama’s innovative analytics solutions. His passion is to help pharma companies operationalize clinical data and accelerate drug development. In 2018, Anisingaraju was awarded a patent for his work using Natural Language Understanding (NLU) for risk and compliance programs. Anisingaraju holds a BS from Andhra University and an MS from Indian Institute of Technology (IIT) Kanpur. He is a featured industry speaker and frequent industry association contributor, and has served on the board of ISACA, Silicon Valley Chapter, as Vice President and Director.
Message PresenterWho Should Attend?
Senior professionals from large to medium mid-market pharma/biotech companies and CROs involved in:
- Clinical Operations
- Clinical Research & Development
- Data Analytics, Engineering & Stewardship
- Data Management
- Medical Affairs / Chief Medical Office
- Regulatory Affairs
- Strategic Planning
The session will benefit companies with working on Phase I-IV clinical studies.
What You Will Learn
- Industry benchmarks for clinical data volume and diversity
- Pre- and post-pandemic innovation adoption practices
- Anticipated long-term operating model changes
Xtalks Partner
Saama
Saama is the #1 AI clinical analytics platform company, enabling the life sciences industry to conduct faster and safer clinical development and regulatory programs. Today, 50 biotech companies use Saama’s award-winning Life Science Analytics Cloud (LSAC) platform on over 1,500 studies, including many of the top 20 pharmaceutical companies. LSAC’s rich applications facilitate an unprecedented, authoritative oversight of comprehensive clinical research data, enabling companies to file New Drug Applications (NDAs) more efficiently and bring drugs to market faster. Discover more at www.saama.com and follow Saama @SaamaTechInc
Related Webinars
Active Surveillance: A New Paradigm in Patient Safety
Metadata-Driven Approach for Clinical Data Lakes
How to Destroy Clinical Data Silos
You Must Login To Register for this Free Webinar
Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.
Create Account